Stephen J. Schueler, M.D.

Overview Incidence Symptoms Evaluation Treatment questions for doctor specialist Warning Signs Outlook Underlying Cause

Acute Demyelinating Polyneuropathy Treatment

Treatment for Guillain-Barre syndrome includes plasmapheresis, immunoglobulins, physical therapy, and mechanical ventilation.

Treatment for Guillain-Barre syndrome includes:

  • Plasmapheresis or plasma exchange therapy for Guillain-Barre syndrome:
    • Filtering the blood to remove proteins made by the immune system
    • Albumin (Albuminar, Albumisol, Albunex, Albutein)
  • High-dose immunoglobulin therapy for Guillain-Barre syndrome:
    • Large doses of immune system proteins from donors' blood
Intravenous immune globulin (IVIG, Gammagard S/D)
  • Physical therapy for Guillain-Barre syndrome:
    • Inactivity can cause joints to become stiff and limit range of motion
  • Low molecular weight heparins:
  • Severe cases may require mechanical ventilation

Acute Demyelinating Polyneuropathy Questions For Doctor

The following are some important questions to ask before and after the treatment of Guillain-Barre syndrome.

Questions to ask before treatment:

  • What are my treatment options?
  • What are the risks associated with treatment?
  • Do I need to stay in the hospital?
    • How long will I be in the hospital?
  • What are the complications I should watch for?
  • How long will I be on medication?
  • What are the potential side effects of my medication?
  • Does my medication interact with nonprescription medicines or supplements?
  • Should I take my medication with food?

Questions to ask after treatment:
  • Do I need to change my diet?
  • Are there any medications or supplements I should avoid?
  • When can I resume my normal activities?
  • When can I return to work?
  • Do I need a special exercise program?
  • Will I need physical therapy?
  • Will I need occupational therapy?
  • How often will I need to see my doctor for checkups?
  • What local support and other resources are available?

Acute Demyelinating Polyneuropathy Specialist

Physicians from the following specialties evaluate and treat Guillain-Barre syndrome:

Continue to Acute Demyelinating Polyneuropathy Warning Signs

Last Updated: Dec 14, 2010 References
Authors: Stephen J. Schueler, MD; John H. Beckett, MD; D. Scott Gettings, MD
Copyright DSHI Systems, Inc. Powered by: FreeMD - Your Virtual Doctor

PubMed Acute Demyelinating Polyneuropathy References
  1. Awong IE, Dandurand KR, Keeys CA, Maung-Gyi FA: Drug-associated Guillain-Barre syndrome: a literature review. Ann Pharmacother 1996 Feb; 30(2): 173-80. [8835052]
  2. Hughes RA, Wijdicks EF, Benson E, Cornblath DR, Hahn AF, Meythaler JM, Sladky JT, Barohn RJ, Stevens JC; Multidisciplinary Consensus Group. Supportive care for patients with guillain-barre syndrome. Arch Neurol. 2005 Aug;62(8):1194-8. [16087757]
  3. van Doorn PA. Treatment of Guillain-Barre syndrome and CIDP. J Peripher Nerv Syst. 2005 Jun;10(2):113-27. [15958124]
FreeMD is provided for information purposes only and should not be used as a substitute for evaluation and treatment by a physician. Please review our terms of use.